Uterine Cervical Diseases: Clinical Trials

2,525 trials for Uterine Cervical Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1095 completed, 489 unknown, 383 recruiting, 166 terminated. 780 Not applicable, 622 Phase 2, 402 Phase 1, 227 Phase 3, 50 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable780Completed 369, Unknown 141, Recruiting 127, Active not recruiting 46, Not yet recruiting 44, Terminated 27, Enrolling by invitation 14, Withdrawn 12
Phase 2622Completed 229, Recruiting 107, Unknown 98, Terminated 69, Not yet recruiting 46, Active not recruiting 40, Withdrawn 29, Enrolling by invitation 2, Suspended 2
Phase 1402Completed 172, Recruiting 69, Terminated 56, Unknown 45, Active not recruiting 32, Withdrawn 16, Not yet recruiting 8, Suspended 3, Enrolling by invitation 1
Phase 3227Completed 118, Unknown 43, Recruiting 24, Terminated 15, Active not recruiting 11, Not yet recruiting 7, Withdrawn 7, Enrolling by invitation 1, Suspended 1
Phase 450Completed 24, Unknown 12, Recruiting 7, Not yet recruiting 5, Terminated 2
Early Phase 128Completed 12, Unknown 9, Active not recruiting 2, Recruiting 2, Terminated 2, Withdrawn 1

Follow Uterine Cervical Diseases: new trials by email Literature Review of Uterine Cervical Diseases trials Research Report on Uterine Cervical Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Papilozumib Vaginal Gel for Exocervical Mucosal Restoration in Women With Human Papillomavirus (HPV)
Papilozumib vaginal gel, Papilozumib oral supplement - Human Papillomavirus Infection, Human Papillomavirus Infections
Not applicableNot yet recruitingHifas da Terra S.L.812027-07-012026-10-05
Development of Systems and Education for Cervical Cancer Prevention (DOSE-CC)
DOSE-CC Intervention: Educational Sessions - Cervical Cancer Screening, Cervical Cancer
Not applicableNot yet recruitingBoston Medical Center800002027-05-012026-10-30
Topical Curcumin for HPV Related Cervical Disease
Curcumin C3 Complex, Placebo - Neoplasm Cervix
Phase 2Not yet recruitingLisa Flowers2002027-04-012026-05-08
Cancer Awareness Among Syrian Migrants
PMT-Based Cancer Screening Educational Intervention, PMT-Based Cancer Screening Education Program - Breast Cancer Screening, Cervical Cancer Screening
Not applicableNot yet recruitingToros University302027-03-092026-10-15
Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.
Gardasil 9 vaccine, Hepatitis B Virus Vaccine(HBV), Cognitive Behavioral Therapy - Hepatitis B, Human Papilloma Virus
Phase 4Not yet recruitingEunice Dube21402027-01-302026-07-30
My Self-Sampling for HPV Awareness, Results, and Empowerment
MySHARE+ mHealth Education Intervention, Healthcare Provider Prompt - Cervical Cancer, Cervical Cancer Screening
Not applicableNot yet recruitingDaisy Le1302027-01-012026-08-18
Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer
Telaglenastat, Radiation treatment, Cisplatin - Advanced Cervical Carcinoma, Cervical Cancer
Phase 2Not yet recruitingWashington University School of Medicine422026-12-312026-09-03
Vaginal Dose De-escalation During Brachytherapy for Cervical Cancer
radiation dose de-escalation - Cervical Cancer
Not applicableNot yet recruitingDuke University202026-12-012026-10-02
COQ10 and Vitamin E for Off-Target Radiation Toxicity
Coenzyme Q10 Cap/Tab, Vitamin E Cap/Tab - Prostate Cancer, Uterine Cancer
Phase 1 / Phase 2Not yet recruitingUniversity of Nebraska2002026-12-012026-10-08
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial
Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging - Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8
Phase 2Not yet recruitingFred Hutchinson Cancer Center502026-12-012026-09-17
High-risk HPV Testing With Pap Smear Triage for Cervical Cancer Screening in Women Aged 50 and Older in Ethiopia
Uterine Cervical Neoplasms, Papillomavirus Infections
Not yet recruitingUniversity Medical Center Groningen30002026-12-012026-11-10
Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya
5% 5-fluorouracil Topical Cream, Placebo Cream - HIV Infections, HPV Infection
Phase 2Not yet recruitingUNC Lineberger Comprehensive Cancer Center1402026-12-012026-11-17
Effect of Web-Based Education on Attitudes and Beliefs About HPV Testing
Web-Based Health Education - Cervical Cancer, HPV
Not applicableNot yet recruitingSakarya University1202026-12-012026-11-16
Ultrashort Echo Time (UTE) MRI for Applicator Reconstruction in Gynaecologic Cancer Brachytherapy
Ultrashort Echo Time (UTE) MRI - Cervical Cancer, Endometrium Cancer
Not applicableNot yet recruitingMahidol University502026-12-012026-11-16
Gut Microbiome in Patients With Lung and Melanoma Cancer and Intestinal Microbiota in Gynecologic Cancers
sample collection - Non Small Cell Lung Cancer, Melanoma (Skin Cancer)
Not applicableNot yet recruitingEuropean Institute of Oncology3602026-11-112026-11-04
C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the United States
Qualitative interviews, Focus groups - Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV)
Not yet recruitingUNC Lineberger Comprehensive Cancer Center35002026-11-102026-10-20
C2001P-CS3: Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV
HPV DNA Testing (Abbott Alinity m HPV Assay), Visual Inspection with Acetic Acid, Cervical Histology (Biopsy Procedures) - Human Papillomavirus (HPV), HPV Associated Cancers
Not applicableRecruitingUniversity of California, San Diego7502026-11-092026-11-12
Tucatinib Continuation Study
tucatinib - HER2-positive Breast Cancer, Cervical Cancer
Phase 4Not yet recruitingPfizer1752026-11-062026-08-28
A Trial of Pembrolizumab With Chemotherapy or Chemoradiotherapy in Participants From India With Different Types of Cancer (MK-3475-G44/KEYNOTE-G44)
Pembrolizumab, Cisplatin, 5-Fluorouracil - Neoplasm Malignant, Gastric Neoplasms
Phase 4Not yet recruitingMerck Sharp & Dohme LLC1502026-11-062026-09-03
Exploratory Study of the Efficacy of HAL-PDT in CIN 3
Hexaminolevulinate (HAL) - Cervical Intraepithelial Neoplasia Grade 3
Phase 2Not yet recruitingTongji Hospital2602026-11-012026-10-23

Showing 20 of 2525. Sign in to see all of them.

Narrower conditions

Uterine Cervical Neoplasms (2252)  ·  Uterine Cervical Dysplasia (388)  ·  Endometrial Neoplasms (330)  ·  Ovarian Neoplasms (321)  ·  Breast Neoplasms (219)  ·  Papillomavirus Infections (200)  ·  Vulvar Neoplasms (157)  ·  Carcinoma, Non-Small-Cell Lung (154)  ·  Neoplasms (153)  ·  Vaginal Neoplasms (141)  ·  Stomach Neoplasms (135)  ·  Colorectal Neoplasms (130)  ·  Esophageal Neoplasms (123)  ·  Prostatic Neoplasms (116)  ·  Urinary Bladder Neoplasms (116)

Broader conditions

Female Urogenital Diseases (2524)  ·  Female Urogenital Diseases and Pregnancy Complications (2523)  ·  Genital Diseases (2523)  ·  Urogenital Diseases (2523)  ·  Genital Diseases, Female (2515)  ·  Uterine Diseases (2515)  ·  Neoplasms (2322)  ·  Neoplasms by Site (2245)  ·  Urogenital Neoplasms (2243)  ·  Genital Neoplasms, Female (2232)  ·  Uterine Neoplasms (2152)  ·  Pathological Conditions, Signs and Symptoms (505)  ·  Pathologic Processes (413)  ·  Endocrine System Diseases (401)

Interventions

Cisplatin (187)  ·  Paclitaxel (84)  ·  Radiotherapy (82)  ·  Brachytherapy (75)  ·  Carboplatin (75)  ·  pembrolizumab (70)  ·  Bevacizumab (42)  ·  Colposcopy (34)  ·  Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (33)  ·  Gemcitabine (31)  ·  Surveys and Questionnaires (29)  ·  Topotecan (29)  ·  Radiation (28)  ·  Blood Specimen Collection (25)  ·  human papillomavirus vaccine, L1 type 16, 18 (25)

Sponsors

National Cancer Institute (NCI) (74)  ·  M.D. Anderson Cancer Center (57)  ·  Gynecologic Oncology Group (46)  ·  GlaxoSmithKline (42)  ·  Merck Sharp & Dohme LLC (30)  ·  Peking Union Medical College Hospital (28)  ·  Tata Memorial Hospital (27)  ·  Lei Li (23)  ·  UNC Lineberger Comprehensive Cancer Center (22)  ·  University of Aarhus (22)  ·  Duke University (19)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (19)  ·  Huazhong University of Science and Technology (19)  ·  Sun Yat-sen University (18)  ·  University Health Network, Toronto (18)

Countries

United States (884)  ·  China (447)  ·  France (155)  ·  Canada (140)  ·  Italy (104)  ·  South Korea (99)  ·  United Kingdom (98)  ·  Spain (92)  ·  Germany (83)  ·  Taiwan (74)  ·  Belgium (67)  ·  Australia (63)  ·  India (61)  ·  Netherlands (57)  ·  Brazil (55)

Top investigators

Lei Li, M.D. (18)  ·  Michele Follen, MD, PhD (9)  ·  Kathleen Schmeler, MD (7)  ·  Rachel L Winer, PhD, MPH (7)  ·  Michael Milosevic, MD (6)  ·  Ting Wu, Ph. D. (6)  ·  Ziad Hilal, M.D. (6)  ·  Chi-An Chen, MD (5)  ·  Ding Ma, MD, PhD (5)  ·  Anthony Fyles, MD (4)

Results publications

PMID 41276263, PMID 30380365, PMID 32779730, PMID 41166720, PMID 19236277, PMID 19236279, PMID 19935017, PMID 21444871, PMID 22914404, PMID 27422279, PMID 30982556, PMID 31824976, PMID 32184277, PMID 37496366, PMID 37650664, PMID 41044356, PMID 19586656, PMID 19949018, PMID 20949623, PMID 21471141, PMID 21840137, PMID 21841155, PMID 21907959, PMID 22002018, PMID 22454089, PMID 23066159, PMID 23299013, PMID 23489374, PMID 23632723, PMID 23843155, PMID 24201682, PMID 24435414, PMID 24807330, PMID 25071111, PMID 25207403, PMID 26348120, PMID 26438146, PMID 27319286, PMID 27432417, PMID 28173776, PMID 29074187, PMID 29211620, PMID 29269325, PMID 29767739, PMID 29995724, PMID 30195193, PMID 32161969, PMID 32894896, PMID 33326342, PMID 33794207

NIH funding

U10CA027469 (25), 2023 (22), 2019 (14), U10CA180868 (13), 2018 (11), U24CA275417 (10), 2009 (7), 2017 (7), 2008 (6), 2015 (6), P30CA016672 (6), 2014 (5), 2016 (5), 2025 (5), P30CA033572 (5)